Table 1.
Biochemical investigations of the patient at admission and during follow-up
| Test | At admission | 3rd day | 1 week | 1 month | Normal range SI units |
| Serum calcium (corrected) | 3.29 mmol/L | 2.79 mmol/L | 2.45 mmol/L | 2.3 mmol/L | 2.12–2.62 mmol/L |
| Serum phosphorus | 0.97 mmol/L | 0.81–1.45 mmol/L | |||
| Serum 25 OH Vit D | 98.34 nmol/L | 74.8–125 nmol/L | |||
| Serum iPTH | 3.3 ng/mL | 15–18 ng/mL | |||
| Serum FT4 | 47.87 pmol/L | – | 25.23 pmol/L | 16.34 pmol/L | 11.4–22.6 pmol/L |
| Serum TSH | 0.007 mIU/L | <0.005 mIU/L | 0.5–4.5 mIU/L | ||
| TSH-R Ab | 26.82 IU/L | <1.22 IU/L | |||
| Serum uric acid | 892.2 µmol/L | 731.6 µmol/L | 410.41 µmol/L | 380.67 µmol/L | 209–428.3 µmol/L |
| Serum creatinine | 91.96 umol/L | 61.9–104 µmol/L | |||
| 24-hour urine calcium | 4.46 µmol /24 hours | 6.16–2.64 µmol/24 hours | |||
| Serum CA 125 | 6.10 U/mL | <35 U/mL | |||
| Serum CEA | 0.76 µg/L | <5 μg/L | |||
| Serum ACE | 82 U/L | 12–68 U/L | |||
| Serum AFP | 1.40 µg/L | <10 μg/L | |||
| Serum b HCG | <2 IU/L | <2 IU/L | |||
| Urine Bence-Jones protein | Negative |
ACE, Angiotensin Converting Enzyme; AFP, Alpha fetoprotein; b HCG, beta Human Chorionic Gonadotropin; CEA, Carcinoembryonic antigen; fT4, Free thyroxine; iPTH, Intact Parathyroid hormone; TSH, thyroid-stimulating hormone; TSH-R Ab, TSH receptor antibodies.